|
Market Closed -
Nasdaq
16:00:00 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 141.33 USD | -2.17% |
|
+16.65% | -18.79% |
| 11-20 | Insmed Insider Sold Shares Worth $14,685,602, According to a Recent SEC Filing | MT |
| 11-20 | Global markets live: Anthropic, Nvidia, AMD, Intuit, Meta… |
Company Valuation: Insmed Incorporated
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,224 | 2,707 | 4,433 | 12,351 | 37,118 | 31,005 | - | - |
| Change | - | -16.05% | 63.79% | 178.59% | 200.52% | -16.47% | - | - |
| Enterprise Value (EV) 1 | 3,089 | 2,863 | 4,993 | 12,209 | 36,229 | 30,491 | 30,056 | 29,179 |
| Change | - | -7.33% | 74.42% | 144.52% | 196.74% | -15.84% | -1.43% | -2.92% |
| P/E | -7.02x | -5.11x | -5.8x | -12.4x | -27.1x | -87.5x | 202x | 43.4x |
| PBR | 6.82x | 30.8x | -13.1x | 39.7x | 46.9x | 48.1x | 30.5x | 17.7x |
| PEG | - | -6.61x | -0.2x | -2.88x | -1.8x | 1.2x | -1x | 0x |
| Capitalization / Revenue | 17.1x | 11x | 14.5x | 34x | 61.2x | 16.7x | 10.4x | 7.82x |
| EV / Revenue | 16.4x | 11.7x | 16.4x | 33.6x | 59.7x | 16.4x | 10.1x | 7.36x |
| EV / EBITDA | -8.58x | -6.4x | -7.14x | -14.1x | -29.4x | -94.1x | 150x | 34.3x |
| EV / EBIT | -8.24x | -6.26x | -7.04x | -13.9x | -29.1x | -97x | 148x | 35.7x |
| EV / FCF | -8.34x | -6.98x | -9.09x | -17.3x | -37.4x | -102x | -1,408x | 43.2x |
| FCF Yield | -12% | -14.3% | -11% | -5.78% | -2.67% | -0.98% | -0.07% | 2.31% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.88 | -3.91 | -5.34 | -5.57 | -6.42 | -1.614 | 0.6994 | 3.257 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 188.5 | 245.4 | 305.2 | 363.7 | 606.4 | 1,861 | 2,990 | 3,963 |
| EBITDA 1 | -359.8 | -447 | -699 | -867.2 | -1,230 | -324 | 200.6 | 849.8 |
| EBIT 1 | -375.1 | -457.3 | -709.6 | -878.3 | -1,247 | -314.3 | 203.1 | 816.3 |
| Net income 1 | -434.7 | -481.5 | -749.6 | -913.8 | -1,277 | -351.6 | 163.8 | 756.1 |
| Net Debt 1 | -135.5 | 155.8 | 559.5 | -142.4 | -889.1 | -514.5 | -949 | -1,826 |
| Reference price 2 | 27.24 | 19.98 | 30.99 | 69.04 | 174.04 | 141.33 | 141.33 | 141.33 |
| Nbr of stocks (in thousands) | 118,372 | 135,477 | 143,062 | 178,903 | 213,273 | 219,380 | - | - |
| Announcement Date | 2/17/22 | 2/23/23 | 2/22/24 | 2/20/25 | 2/19/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -87.55x | 16.38x | -94.1x | -.--% | 31.01B | ||
| 16.7x | 6.32x | 12.11x | 1.79% | 63.66B | ||
| 31.66x | 8.45x | 27.93x | 0.07% | 58.56B | ||
| 37.7x | 6.72x | 20.09x | 0.86% | 54.19B | ||
| 40.47x | 5.8x | 27.69x | -.--% | 44.66B | ||
| 32.08x | 3.11x | 13.42x | -.--% | 40.51B | ||
| 36.47x | 8.88x | 23.19x | 0.36% | 36.27B | ||
| -19.34x | 51.61x | -20.92x | -.--% | 34.89B | ||
| 41.15x | 7.94x | 26.62x | -.--% | 32.26B | ||
| 24.78x | 5.18x | 13.43x | -.--% | 21.45B | ||
| Average | 15.41x | 12.04x | 4.95x | 0.31% | 42B | |
| Weighted average by Cap. | 18.83x | 11.12x | 8.66x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INSM Stock
- Valuation Insmed Incorporated
Select your edition
All financial news and data tailored to specific country editions
















